{
    "organizations": [],
    "uuid": "29ce42d29987c9937300a63e7c9924035a442ef2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-hemostemix-finalizes-terms-of-lice/brief-hemostemix-finalizes-terms-of-license-agreement-with-aspire-health-science-idUSFWN1QG0UG",
    "ord_in_thread": 0,
    "title": "BRIEF-Hemostemix Finalizes Terms Of License Agreement With Aspire Health Science",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 42 PM / Updated 12 minutes ago BRIEF-Hemostemix Finalizes Terms Of License Agreement With Aspire Health Science Reuters Staff 1 Min Read Feb 26 (Reuters) - Hemostemix Inc: * HEMOSTEMIX INC - ‍ FINALIZED TERMS OF A LICENSE AGREEMENT WITH ASPIRE HEALTH SCIENCE FOR ACP-01​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-26T15:40:00.000+02:00",
    "crawled": "2018-02-26T16:01:41.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "finalizes",
        "term",
        "license",
        "agreement",
        "aspire",
        "health",
        "science",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "hemostemix",
        "inc",
        "hemostemix",
        "inc",
        "finalized",
        "term",
        "license",
        "agreement",
        "aspire",
        "health",
        "science",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}